Clinical Research & Medicines
The Next Era of Cancer Research
May 27, 2025
Driving innovation for a brighter future for patients
By: Regeneron
.jpg)
This is an exciting time in cancer research. The field has seen tremendous advances over the last decade and continues to progress each and every day. We're hopeful about a future where cancer has the potential to be managed in the way that many chronic diseases are today.
To help shape that future, we’re working relentlessly to unlock potential new approaches and combinations. We’re pushing the boundaries of existing innovations — particularly in fields like immunotherapy — and using an iterative approach to research aimed at uncovering new possibilities. We trust and follow science, take on the biggest challenges and focus on critical needs where treatment options are limited or non-existent.
Backed by our unique ability to repeatedly and consistently translate science into medicine, we’re pursuing breakthrough discoveries and potential treatment approaches — because we believe a revolution in cancer treatment is just around the corner.
Learn more about our approach here.
"What sets Regeneron apart from other companies that work in oncology is the mindset. What really drives our decisions is the science, so it doesn't matter if it is in a small or a big indication. If the science says that we should pursue that one, we go for it.”
Karen Rodriguez Lorenc
“Ultimately, my hope for the future is that we're able to unlock the right combinations so that all types of cancers can be treated and reduced to chronic diseases.”
Izzy Lowy
"And when I think about the science and the innovation that has led to breakthroughs in cancer treatment over the last several years, I really believe that Regeneron is the company that's going to take it to the next level."
Justin Holko
To hear more perspectives from our leaders, visit our Human Elements Playlist.